High Tibial Osteotomy (HTO) Plates Market by Material (Metals and Polymers), and Technique (Open Wedge Technique, Closed Wedge Technique, and Other): Global Opportunity Analysis and Industry Forecast, 2017 - 2023
High Tibial Osteotomy (HTO) Plates Market Overview:
The global high tibial osteotomy (HTO) market generated $215 million in 2016 and is expected to reach $269 million by 2023, registering a CAGR of 3.2% from 2017 to 2023. High tibial osteotomy is an orthopedic surgical procedure that targets at correcting a varus deformation with compartmental osteoarthritis. High tibial osteotomy is largely implied in the treatment of younger patients, who are more active.
Increase in the incidence rate of bone-related diseases caused by improper diet or unhealthy lifestyle is the major factor that drives the growth of the high tibial osteotomy plates market. In addition, rise in number of road accidents, surge in geriatric population, and high adoption of surgical procedures for safe diagnosis and treatment of bone-related diseases are the factors further expected to boost the market growth. However, expensive procedural cost of osteotomy surgeries and adverse effects associated with the use of plates are expected to hamper the market growth. Rise in healthcare infrastructure and healthcare investment, and untapped market opportunities in the developing regions are expected to provide numerous opportunities for the market.
The global high tibial osteotomy (HTO) plates market is segmented based on material, technique, and region. By material, the market is bifurcated into metals and polymers. Based on technique, it is classified into open wedged technique, closed wedge technique, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for High Tibial Osteotomy (HTO) Plates Market:
The global high tibial osteotomy (HTO) market generated $215 million in 2016 and is expected to reach $269 million by 2023, registering a CAGR of 3.2% from 2017 to 2023. High tibial osteotomy is an orthopedic surgical procedure that targets at correcting a varus deformation with compartmental osteoarthritis. High tibial osteotomy is largely implied in the treatment of younger patients, who are more active.
Increase in the incidence rate of bone-related diseases caused by improper diet or unhealthy lifestyle is the major factor that drives the growth of the high tibial osteotomy plates market. In addition, rise in number of road accidents, surge in geriatric population, and high adoption of surgical procedures for safe diagnosis and treatment of bone-related diseases are the factors further expected to boost the market growth. However, expensive procedural cost of osteotomy surgeries and adverse effects associated with the use of plates are expected to hamper the market growth. Rise in healthcare infrastructure and healthcare investment, and untapped market opportunities in the developing regions are expected to provide numerous opportunities for the market.
The global high tibial osteotomy (HTO) plates market is segmented based on material, technique, and region. By material, the market is bifurcated into metals and polymers. Based on technique, it is classified into open wedged technique, closed wedge technique, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for High Tibial Osteotomy (HTO) Plates Market:
- This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities for the market.
- Market size and estimations are based on a comprehensive analysis of the materials and technique in the industry.
- The study provides region-wise market share analysis to understand the competitive outlook of the regional market.
- In-depth geographical analysis facilitates in analyzing the regional market to assist in strategic business planning.
- By Material
- Metals
- Polymers
- By Technique
- Open Wedge Technique
- Closed Wedge Technique
- Other
- By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
- DePuy Synthes (Johnson & Johnson)
- Arthrex, Inc.
- Zimmer Biomet
- aap Implantate AG
- Stryker Corporation
- B. Braun Melsungen AG
- Smith & Nephew
- Wright Medical Group N.V.
- Acumed, LLC
- Amplitude Surgical
- TriMed, Inc.
- Tornier, Inc.
- Medical & Optical Instruments Australia Pty Ltd
- Novastep Inc.
- Integra LifeSciences Corporation
- Securos
- BioTek Instruments, Inc.
- GROUP FH ORTHO
- OrthoPediatrics Corp
CHAPTER: 1: INTRODUCTION
1.1. Report description
1.2. Key market benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER: 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Government Regulations
3.3.1. U.S.
3.3.2. European Union
3.3.3. Japan
3.4. Market share analysis, 2016
3.5. Porter’s five forces analysis
3.6. Market dynamics
3.6.1. Drivers
3.6.1.1. Rise in the incidence of bone-associated disorders across the globe
3.6.1.2. Technological advancements in the high tibial osteotomy plates
3.6.1.3. Rising geriatric population susceptible to bone disorders and increase in the number of road accidents
3.6.2. Restraints
3.6.2.1. High costs associated with HTO procedure
3.6.2.2. Surgical complications related to HTO along with the increasing preference for alternative treatment methods
3.6.3. Opportunity
3.6.3.1. Growth in healthcare infrastructure and increase in healthcare investment in emerging nations
3.7. Procedure Volume for High Tibial Osteotomy
3.7.1. Global High Tibial Osteotomy (HTO) Procedures
3.7.2. High Tibial Osteotomy (HTO) Procedures by Material
3.7.3. High Tibial Osteotomy (HTO) Procedures by Technique
3.7.4. High Tibial Osteotomy (HTO) Procedures by Region
CHAPTER: 4: HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY MATERIAL
4.1. Overview
4.1.1. Market size and forecast
4.2. Metals
4.2.1. Market size and forecast
4.3. Polymers
4.3.1. Market size and forecast
CHAPTER: 5: HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY TECHNIQUE
5.1. Overview
5.1.1. Market size and forecast
5.2. Open Wedge Technique
5.2.1. Market size and forecast
5.3. Closed Wedge Technique
5.3.1. Market size and forecast
5.4. Other
5.4.1. Market size and forecast
CHAPTER: 6: HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. North America market size and forecast, by country
6.2.1.1. U.S. market size and forecast
6.2.1.2. Canada market size and forecast
6.2.1.3. Mexico market size and forecast
6.2.2. North America market size and forecast, by material
6.2.3. North America market size and forecast, by technique
6.3. Europe
6.3.1. Europe market size and forecast, by country
6.3.1.1. UK market size and forecast
6.3.1.2. France market size and forecast
6.3.1.3. Germany market size and forecast
6.3.1.4. Spain market size and forecast
6.3.1.5. Rest of Europe market size and forecast
6.3.2. Europe market size and forecast, by material
6.3.3. Europe market size and forecast, by technique
6.4. Asia-Pacific
6.4.1. Asia-Pacific market size and forecast, by country
6.4.1.1. China market size and forecast
6.4.1.2. Japan market size and forecast
6.4.1.3. India market size and forecast
6.4.1.4. Australia market size and forecast
6.4.1.5. Rest of Asia-Pacific market size and forecast
6.4.2. Asia-Pacific market size and forecast, by material
6.4.3. Asia-Pacific market size and forecast, by technique
6.5. LAMEA
6.5.1. LAMEA market size and forecast, by country
6.5.1.1. Brazil market size and forecast
6.5.1.2. Saudi Arabia market size and forecast
6.5.1.3. South Africa market size and forecast
6.5.1.4. Rest of LAMEA market size and forecast
6.5.2. LAMEA market size and forecast, by material
6.5.3. LAMEA market size and forecast, by technique
CHAPTER: 7: COMPANY PROFILES
7.1. Johnson & Johnson (DePuy Synthes)
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. Arthrex, Inc.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. Zimmer Biomet
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. aap Implantate AG
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. Stryker Corporation
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. B. Braun Melsungen AG
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. Smith & Nephew Plc.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. Wright Medical Group N.V.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. Acumed, LLC
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.10. Amplitude Surgical
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
1.1. Report description
1.2. Key market benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER: 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Government Regulations
3.3.1. U.S.
3.3.2. European Union
3.3.3. Japan
3.4. Market share analysis, 2016
3.5. Porter’s five forces analysis
3.6. Market dynamics
3.6.1. Drivers
3.6.1.1. Rise in the incidence of bone-associated disorders across the globe
3.6.1.2. Technological advancements in the high tibial osteotomy plates
3.6.1.3. Rising geriatric population susceptible to bone disorders and increase in the number of road accidents
3.6.2. Restraints
3.6.2.1. High costs associated with HTO procedure
3.6.2.2. Surgical complications related to HTO along with the increasing preference for alternative treatment methods
3.6.3. Opportunity
3.6.3.1. Growth in healthcare infrastructure and increase in healthcare investment in emerging nations
3.7. Procedure Volume for High Tibial Osteotomy
3.7.1. Global High Tibial Osteotomy (HTO) Procedures
3.7.2. High Tibial Osteotomy (HTO) Procedures by Material
3.7.3. High Tibial Osteotomy (HTO) Procedures by Technique
3.7.4. High Tibial Osteotomy (HTO) Procedures by Region
CHAPTER: 4: HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY MATERIAL
4.1. Overview
4.1.1. Market size and forecast
4.2. Metals
4.2.1. Market size and forecast
4.3. Polymers
4.3.1. Market size and forecast
CHAPTER: 5: HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY TECHNIQUE
5.1. Overview
5.1.1. Market size and forecast
5.2. Open Wedge Technique
5.2.1. Market size and forecast
5.3. Closed Wedge Technique
5.3.1. Market size and forecast
5.4. Other
5.4.1. Market size and forecast
CHAPTER: 6: HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. North America market size and forecast, by country
6.2.1.1. U.S. market size and forecast
6.2.1.2. Canada market size and forecast
6.2.1.3. Mexico market size and forecast
6.2.2. North America market size and forecast, by material
6.2.3. North America market size and forecast, by technique
6.3. Europe
6.3.1. Europe market size and forecast, by country
6.3.1.1. UK market size and forecast
6.3.1.2. France market size and forecast
6.3.1.3. Germany market size and forecast
6.3.1.4. Spain market size and forecast
6.3.1.5. Rest of Europe market size and forecast
6.3.2. Europe market size and forecast, by material
6.3.3. Europe market size and forecast, by technique
6.4. Asia-Pacific
6.4.1. Asia-Pacific market size and forecast, by country
6.4.1.1. China market size and forecast
6.4.1.2. Japan market size and forecast
6.4.1.3. India market size and forecast
6.4.1.4. Australia market size and forecast
6.4.1.5. Rest of Asia-Pacific market size and forecast
6.4.2. Asia-Pacific market size and forecast, by material
6.4.3. Asia-Pacific market size and forecast, by technique
6.5. LAMEA
6.5.1. LAMEA market size and forecast, by country
6.5.1.1. Brazil market size and forecast
6.5.1.2. Saudi Arabia market size and forecast
6.5.1.3. South Africa market size and forecast
6.5.1.4. Rest of LAMEA market size and forecast
6.5.2. LAMEA market size and forecast, by material
6.5.3. LAMEA market size and forecast, by technique
CHAPTER: 7: COMPANY PROFILES
7.1. Johnson & Johnson (DePuy Synthes)
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. Arthrex, Inc.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. Zimmer Biomet
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. aap Implantate AG
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. Stryker Corporation
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. B. Braun Melsungen AG
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. Smith & Nephew Plc.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. Wright Medical Group N.V.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. Acumed, LLC
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.10. Amplitude Surgical
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 01. GLOBAL HIGH TIBIAL OSTEOTOMY (HTO) PROCEDURES, 2016-2023 (MILLION PROCEDURES)
TABLE 02. HIGH TIBIAL OSTEOTOMY (HTO) PROCEDURES FOR MATERIAL, 2016-2023 (MILLION PROCEDURES)
TABLE 03. HIGH TIBIAL OSTEOTOMY (HTO) PROCEDURES FOR TECHNIQUE, 2016-2023 (MILLION PROCEDURES)
TABLE 04. HIGH TIBIAL OSTEOTOMY (HTO) PROCEDURES FOR TECHNIQUE, 2016-2023 (MILLION PROCEDURES)
TABLE 05. HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 06. SOME OF THE POPULAR BRANDS OF HTO PLATES IN THE MARKET
TABLE 07. HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 08. HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY REGION, 2016–2023 ($MILLION)
TABLE 09. NORTH AMERICA HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 10. NORTH AMERICA HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY MATERIAL, 2016–2023 ($MILLION)
TABLE 11. NORTH AMERICA HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY TECHNIQUE, 2016–2023 ($MILLION)
TABLE 12. EUROPE HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 13. EUROPE HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY MATERIAL, 2016–2023 ($MILLION)
TABLE 14. EUROPE HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY TECHNIQUE, 2016–2023 ($MILLION)
TABLE 15. ASIA-PACIFIC HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 16. ASIA-PACIFIC HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY MATERIAL, 2016–2023 ($MILLION)
TABLE 17. ASIA-PACIFIC HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY TECHNIQUE, 2016–2023 ($MILLION)
TABLE 18. LAMEA HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 19. LAMEA HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY MATERIAL, 2016–2023 ($MILLION)
TABLE 20. LAMEA HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY TECHNIQUE, 2016–2023 ($MILLION)
TABLE 21. J&J: COMPANY SNAPSHOT
TABLE 22. J&J: OPERATING SEGMENTS
TABLE 23. J&J: PRODUCT PORTFOLIO
TABLE 24. ARTHREX: COMPANY SNAPSHOT
TABLE 25. ARTHREX: OPERATING SEGMENTS
TABLE 26. ARTHREX: PRODUCT PORTFOLIO
TABLE 27. ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 28. ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 29. ZIMMER BIOMET: PRODUCT PORTFOLIO
TABLE 30. AAP IMPLANTATE: COMPANY SNAPSHOT
TABLE 31. AAP IMPLANTATE: OPERATING SEGMENTS
TABLE 32. AAP IMPLANTATE: PRODUCT PORTFOLIO
TABLE 33. STRYKER: COMPANY SNAPSHOT
TABLE 34. STRYKER: OPERATING SEGMENTS
TABLE 35. STRYKER: PRODUCT PORTFOLIO
TABLE 36. B. BRAUN: COMPANY SNAPSHOT
TABLE 37. B. BRAUN: OPERATING SEGMENTS
TABLE 38. B. BRAUN: PRODUCT PORTFOLIO
TABLE 39. SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 40. SMITH & NEPHEW: OPERATING SEGMENTS
TABLE 41. SMITH & NEPHEW: PRODUCT PORTFOLIO
TABLE 42. WRIGHT MEDICAL: COMPANY SNAPSHOT
TABLE 43. WRIGHT MEDICAL: OPERATING SEGMENTS
TABLE 44. WRIGHT MEDICAL: PRODUCT PORTFOLIO
TABLE 45. ACUMED: COMPANY SNAPSHOT
TABLE 46. ACUMED: OPERATING SEGMENTS
TABLE 47. ACUMED: PRODUCT PORTFOLIO
TABLE 48. AMPLITUDE SURGICAL: COMPANY SNAPSHOT
TABLE 49. AMPLITUDE SURGICAL: OPERATING SEGMENTS
TABLE 50. AMPLITUDE SURGICAL: PRODUCT PORTFOLIO
TABLE 01. GLOBAL HIGH TIBIAL OSTEOTOMY (HTO) PROCEDURES, 2016-2023 (MILLION PROCEDURES)
TABLE 02. HIGH TIBIAL OSTEOTOMY (HTO) PROCEDURES FOR MATERIAL, 2016-2023 (MILLION PROCEDURES)
TABLE 03. HIGH TIBIAL OSTEOTOMY (HTO) PROCEDURES FOR TECHNIQUE, 2016-2023 (MILLION PROCEDURES)
TABLE 04. HIGH TIBIAL OSTEOTOMY (HTO) PROCEDURES FOR TECHNIQUE, 2016-2023 (MILLION PROCEDURES)
TABLE 05. HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 06. SOME OF THE POPULAR BRANDS OF HTO PLATES IN THE MARKET
TABLE 07. HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 08. HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY REGION, 2016–2023 ($MILLION)
TABLE 09. NORTH AMERICA HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 10. NORTH AMERICA HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY MATERIAL, 2016–2023 ($MILLION)
TABLE 11. NORTH AMERICA HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY TECHNIQUE, 2016–2023 ($MILLION)
TABLE 12. EUROPE HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 13. EUROPE HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY MATERIAL, 2016–2023 ($MILLION)
TABLE 14. EUROPE HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY TECHNIQUE, 2016–2023 ($MILLION)
TABLE 15. ASIA-PACIFIC HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 16. ASIA-PACIFIC HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY MATERIAL, 2016–2023 ($MILLION)
TABLE 17. ASIA-PACIFIC HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY TECHNIQUE, 2016–2023 ($MILLION)
TABLE 18. LAMEA HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 19. LAMEA HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY MATERIAL, 2016–2023 ($MILLION)
TABLE 20. LAMEA HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET, BY TECHNIQUE, 2016–2023 ($MILLION)
TABLE 21. J&J: COMPANY SNAPSHOT
TABLE 22. J&J: OPERATING SEGMENTS
TABLE 23. J&J: PRODUCT PORTFOLIO
TABLE 24. ARTHREX: COMPANY SNAPSHOT
TABLE 25. ARTHREX: OPERATING SEGMENTS
TABLE 26. ARTHREX: PRODUCT PORTFOLIO
TABLE 27. ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 28. ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 29. ZIMMER BIOMET: PRODUCT PORTFOLIO
TABLE 30. AAP IMPLANTATE: COMPANY SNAPSHOT
TABLE 31. AAP IMPLANTATE: OPERATING SEGMENTS
TABLE 32. AAP IMPLANTATE: PRODUCT PORTFOLIO
TABLE 33. STRYKER: COMPANY SNAPSHOT
TABLE 34. STRYKER: OPERATING SEGMENTS
TABLE 35. STRYKER: PRODUCT PORTFOLIO
TABLE 36. B. BRAUN: COMPANY SNAPSHOT
TABLE 37. B. BRAUN: OPERATING SEGMENTS
TABLE 38. B. BRAUN: PRODUCT PORTFOLIO
TABLE 39. SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 40. SMITH & NEPHEW: OPERATING SEGMENTS
TABLE 41. SMITH & NEPHEW: PRODUCT PORTFOLIO
TABLE 42. WRIGHT MEDICAL: COMPANY SNAPSHOT
TABLE 43. WRIGHT MEDICAL: OPERATING SEGMENTS
TABLE 44. WRIGHT MEDICAL: PRODUCT PORTFOLIO
TABLE 45. ACUMED: COMPANY SNAPSHOT
TABLE 46. ACUMED: OPERATING SEGMENTS
TABLE 47. ACUMED: PRODUCT PORTFOLIO
TABLE 48. AMPLITUDE SURGICAL: COMPANY SNAPSHOT
TABLE 49. AMPLITUDE SURGICAL: OPERATING SEGMENTS
TABLE 50. AMPLITUDE SURGICAL: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS, 2016
FIGURE 03. MARKET SHARE ANALYSIS, 2016
FIGURE 04. NORTH AMERICA MARKET SHARE ANALYSIS, 2016
FIGURE 05. EUROPE MARKET SHARE ANALYSIS, 2016
FIGURE 06. ASIA-PACIFIC MARKET SHARE ANALYSIS, 2016
FIGURE 07. LAMEA MARKET SHARE ANALYSIS, 2016
FIGURE 08. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 09. HIGH BARGAINING POWER OF BUYERS
FIGURE 10. MODERATE THREAT OF SUBSTITUTION
FIGURE 11. HIGH THREAT OF NEW ENTRANTS
FIGURE 12. MODERATE COMPETITIVE RIVALRY
FIGURE 13. GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET: RESTRAINTS, DRIVERS, AND OPPORTUNITY
FIGURE 14. HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET FOR METALS, 2016–2023 ($MILLION)
FIGURE 15. HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET FOR POLYMERS, 2016–2023 ($MILLION)
FIGURE 16. HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET FOR OPEN WEDGE TECHNIQUE, 2016–2023 ($MILLION)
FIGURE 17. HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET FOR CLOSED WEDGE TECHNIQUE, 2016–2023 ($MILLION)
FIGURE 18. HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET FOR OTHER TECHNIQUE, 2016–2023 ($MILLION)
FIGURE 19. HTO PLATES MARKET SIZE AND FORECAST IN U.S.
FIGURE 20. HTO PLATES MARKET SIZE AND FORECAST IN CANADA
FIGURE 21. HTO PLATES MARKET SIZE AND FORECAST IN MEXICO
FIGURE 22. HTO PLATES MARKET SIZE AND FORECAST IN UK
FIGURE 23. HTO PLATES MARKET SIZE AND FORECAST IN FRANCE
FIGURE 24. HTO PLATES MARKET SIZE AND FORECAST IN GERMANY
FIGURE 25. HTO PLATES MARKET SIZE AND FORECAST IN SPAIN
FIGURE 26. HTO PLATES MARKET SIZE AND FORECAST IN REST OF EUROPE
FIGURE 27. HTO PLATES MARKET SIZE AND FORECAST IN CHINA
FIGURE 28. HTO PLATES MARKET SIZE AND FORECAST IN JAPAN
FIGURE 29. HTO PLATES MARKET SIZE AND FORECAST IN INDIA
FIGURE 30. HTO PLATES MARKET SIZE AND FORECAST IN AUSTRALIA
FIGURE 31. HTO PLATES MARKET SIZE AND FORECAST IN REST OF ASIA-PACIFIC
FIGURE 32. HTO PLATES MARKET SIZE AND FORECAST IN BRAZIL
FIGURE 33. HTO PLATES MARKET SIZE AND FORECAST IN SAUDI ARABIA
FIGURE 34. HTO PLATES MARKET SIZE AND FORECAST IN SOUTH AFRICA
FIGURE 35. HTO PLATES MARKET SIZE AND FORECAST IN REST OF LAMEA
FIGURE 36. J&J: NET SALES, 2015–2017 ($MILLION)
FIGURE 37. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 38. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 39. ARTHREX: NET SALES, 2015–2017 ($MILLION)
FIGURE 40. ARTHREX: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 41. ARTHREX: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 42. ZIMMER BIOMET: NET SALES, 2015–2017 ($MILLION)
FIGURE 43. ZIMMER BIOMET: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 44. ZIMMER BIOMET: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 45. AAP IMPLANTATE: NET SALES, 2015–2017 ($MILLION)
FIGURE 46. AAP IMPLANTATE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 47. AAP IMPLANTATE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 48. STRYKER: NET SALES, 2015–2017 ($MILLION)
FIGURE 49. STRYKER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 50. STRYKER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 51. B. BRAUN: NET SALES, 2015–2017 ($MILLION)
FIGURE 52. B. BRAUN: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 53. B. BRAUN: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 54. SMITH & NEPHEW: NET SALES, 2015–2017 ($MILLION)
FIGURE 55. SMITH & NEPHEW: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 56. SMITH & NEPHEW: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 57. WRIGHT MEDICAL: NET SALES, 2015–2017 ($MILLION)
FIGURE 58. WRIGHT MEDICAL: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 59. WRIGHT MEDICAL: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 60. ACUMED: NET SALES, 2015–2017 ($MILLION)
FIGURE 61. ACUMED: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 62. ACUMED: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 63. AMPLITUDE SURGICAL: NET SALES, 2015–2017 ($MILLION)
FIGURE 64. AMPLITUDE SURGICAL: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 65. AMPLITUDE SURGICAL: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 01. GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS, 2016
FIGURE 03. MARKET SHARE ANALYSIS, 2016
FIGURE 04. NORTH AMERICA MARKET SHARE ANALYSIS, 2016
FIGURE 05. EUROPE MARKET SHARE ANALYSIS, 2016
FIGURE 06. ASIA-PACIFIC MARKET SHARE ANALYSIS, 2016
FIGURE 07. LAMEA MARKET SHARE ANALYSIS, 2016
FIGURE 08. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 09. HIGH BARGAINING POWER OF BUYERS
FIGURE 10. MODERATE THREAT OF SUBSTITUTION
FIGURE 11. HIGH THREAT OF NEW ENTRANTS
FIGURE 12. MODERATE COMPETITIVE RIVALRY
FIGURE 13. GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET: RESTRAINTS, DRIVERS, AND OPPORTUNITY
FIGURE 14. HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET FOR METALS, 2016–2023 ($MILLION)
FIGURE 15. HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET FOR POLYMERS, 2016–2023 ($MILLION)
FIGURE 16. HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET FOR OPEN WEDGE TECHNIQUE, 2016–2023 ($MILLION)
FIGURE 17. HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET FOR CLOSED WEDGE TECHNIQUE, 2016–2023 ($MILLION)
FIGURE 18. HIGH TIBIAL OSTEOTOMY (HTO) PLATES MARKET FOR OTHER TECHNIQUE, 2016–2023 ($MILLION)
FIGURE 19. HTO PLATES MARKET SIZE AND FORECAST IN U.S.
FIGURE 20. HTO PLATES MARKET SIZE AND FORECAST IN CANADA
FIGURE 21. HTO PLATES MARKET SIZE AND FORECAST IN MEXICO
FIGURE 22. HTO PLATES MARKET SIZE AND FORECAST IN UK
FIGURE 23. HTO PLATES MARKET SIZE AND FORECAST IN FRANCE
FIGURE 24. HTO PLATES MARKET SIZE AND FORECAST IN GERMANY
FIGURE 25. HTO PLATES MARKET SIZE AND FORECAST IN SPAIN
FIGURE 26. HTO PLATES MARKET SIZE AND FORECAST IN REST OF EUROPE
FIGURE 27. HTO PLATES MARKET SIZE AND FORECAST IN CHINA
FIGURE 28. HTO PLATES MARKET SIZE AND FORECAST IN JAPAN
FIGURE 29. HTO PLATES MARKET SIZE AND FORECAST IN INDIA
FIGURE 30. HTO PLATES MARKET SIZE AND FORECAST IN AUSTRALIA
FIGURE 31. HTO PLATES MARKET SIZE AND FORECAST IN REST OF ASIA-PACIFIC
FIGURE 32. HTO PLATES MARKET SIZE AND FORECAST IN BRAZIL
FIGURE 33. HTO PLATES MARKET SIZE AND FORECAST IN SAUDI ARABIA
FIGURE 34. HTO PLATES MARKET SIZE AND FORECAST IN SOUTH AFRICA
FIGURE 35. HTO PLATES MARKET SIZE AND FORECAST IN REST OF LAMEA
FIGURE 36. J&J: NET SALES, 2015–2017 ($MILLION)
FIGURE 37. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 38. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 39. ARTHREX: NET SALES, 2015–2017 ($MILLION)
FIGURE 40. ARTHREX: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 41. ARTHREX: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 42. ZIMMER BIOMET: NET SALES, 2015–2017 ($MILLION)
FIGURE 43. ZIMMER BIOMET: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 44. ZIMMER BIOMET: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 45. AAP IMPLANTATE: NET SALES, 2015–2017 ($MILLION)
FIGURE 46. AAP IMPLANTATE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 47. AAP IMPLANTATE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 48. STRYKER: NET SALES, 2015–2017 ($MILLION)
FIGURE 49. STRYKER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 50. STRYKER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 51. B. BRAUN: NET SALES, 2015–2017 ($MILLION)
FIGURE 52. B. BRAUN: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 53. B. BRAUN: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 54. SMITH & NEPHEW: NET SALES, 2015–2017 ($MILLION)
FIGURE 55. SMITH & NEPHEW: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 56. SMITH & NEPHEW: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 57. WRIGHT MEDICAL: NET SALES, 2015–2017 ($MILLION)
FIGURE 58. WRIGHT MEDICAL: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 59. WRIGHT MEDICAL: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 60. ACUMED: NET SALES, 2015–2017 ($MILLION)
FIGURE 61. ACUMED: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 62. ACUMED: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 63. AMPLITUDE SURGICAL: NET SALES, 2015–2017 ($MILLION)
FIGURE 64. AMPLITUDE SURGICAL: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 65. AMPLITUDE SURGICAL: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
